Evidence map›Paper›PMID 42012644›Full record

ArticleClinical neuroradiology2026

Automated Deep Learning-Based Demyelination Load Segmentation in Metachromatic Leukodystrophy.

Pascal Martin, Joël Schaerer, Thomas Cajgfinger, Alessandro Delmonte, Benjamin Bender, David Whiteman, C J Malanga, Alexandre Fusellier, David Scott, Joyce Suhy and 3 more

Abstract read
In one paragraph

Article in Clinical neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Pascal MartinDepartment of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. pascal.martin@med.uni-tuebingen.de.
Joël SchaererClario, Inc. (formerly Bioclinica, Inc.), Lyon, France.
Thomas CajgfingerClario, Inc. (formerly Bioclinica, Inc.), Lyon, France.
Alessandro DelmonteClario, Inc. (formerly Bioclinica, Inc.), Lyon, France.
Benjamin BenderDepartment of Diagnostic and Interventional Neuroradiology, University of Tübingen, Tübingen, Germany.
David WhitemanTakeda Pharmaceutical Company Ltd, Cambridge, MA, United States.
C J MalangaTakeda Pharmaceutical Company Ltd, Cambridge, MA, United States.
Alexandre FusellierClario, Inc. (formerly Bioclinica, Inc.), Lyon, France.
David ScottClario, Inc. (formerly Bioclinica, Inc.), San Mateo, CA, United States.
Joyce SuhyClario, Inc. (formerly Bioclinica, Inc.), San Mateo, CA, United States.
Hendrik RosewichDepartment of Pediatric Neurology & Developmental Medicine, University Children's Hospital Tübingen, Tübingen, Germany.
Samuel GroeschelDepartment of Pediatric Neurology & Developmental Medicine, University Children's Hospital Tübingen, Tübingen, Germany.
Luc BracoudClario, Inc. (formerly Bioclinica, Inc.), Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMetachromatic leukodystrophy (MLD) is a rare lysosomal storage disorder characterized by progressive white matter demyelination. Quantification of demyelinated white matter on MRI-typically expressed as the demyelination load-serves as a key imaging biomarker of disease burden, enabling objective monitoring beyond visual rating scales. However, current semi-automated pipelines are limited by manual interaction, pediatric brain variability, and differences in MRI acquisition. This study aimed to develop and validate a self-configuring convolutional neural network (CNN) for automated segmentation of demyelinated white matter in MLD and to compare its performance with a conventional semi-automated method across heterogeneous MRI datasets.

methodsAn nnU-Net was trained on 189 3D T1- and axial T2-weighted scans from 35 MLD patients using visually controlled conventional masks as ground truth. Independent testing was performed on 130 scans (73 high-resolution 3D, 57 lower-resolution 2D T1-weighted) from 49 patients. Performance was assessed by Dice coefficient, Bland-Altman bias, correlation with Gross Motor Function Classification (GMFC-MLD), MLD MRI severity score, longitudinal consistency, and qualitative review of outliers.

resultsCNN-based segmentation showed strong spatial agreement with the reference method, with a median Dice coefficient of 0.82 for 3D T1-weighted scans and 0.75 for 2D scans. Volumetric bias was minimal on Bland-Altman analysis. CNN-derived demyelination load correlated significantly with motor impairment (r

conclusionThe nnU-Net enables fast, reproducible, and clinically meaningful segmentation of demyelinated white matter in MLD. It generalizes across MRI protocols, correlates with motor function, and offers a scalable tool for standardized biomarker extraction in clinical trials and other leukodystrophies.

Indexed as

Deep LearningDemyelinating DiseasesImage Interpretation, Computer-AssistedLeukodystrophy, MetachromaticMagnetic Resonance ImagingChildConvolutional Neural NetworksFemaleHumansMaleReproducibility of ResultsAutomated lesion segmentationConvolutional neural networkDemyelination loadMetachromatic leukodystrophyQuantitative MRI

Identifiers

PMID42012644
PMCPMC13522038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.